Collection of Tissue Samples for Cancer Research
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Background: -Patients who are being evaluated and/or treated at the NIH Clinical Center and adult patients at participating sites will be entered onto this tissue procurement protocol for collection of tissue specimens. Objectives: * To obtain samples from adult and pediatric patients for research purposes from tests and procedures that are done as required by the primary research protocol(s) to which a patient is enrolled or as part of their standard-of-care treatment. * To obtain samples for research purposes from non-surgical procedures, such as percutaneous biopsies, performed for the sole purpose of obtaining tissue specimens or biological fluids for this protocol. Eligibility: -Adult patients (18 years of age and older) and pediatric patients (younger than 18 years of age) who are being evaluated for and/or treated for cancer at the NIH Clinical Center participating sites. Design: * This is a multicenter tissue procurement protocol with NCI as the coordinating center. * For adult patients: specimens for research purposes, as outlined in this protocol, will be obtained from tests and procedures that are done as required by the primary research protocols to which a patient is enrolled or as part of their standard-of-care treatment. Non-surgical procedures, such as percutaneous biopsies, may also be performed for the sole purpose of obtaining tissue specimens or biological fluids for this protocol. Tissues and biological fluids to be procured may include but are not limited to blood, serum, urine, tumor tissue, normal tissue, pleural fluid, CSF, saliva, bronchial alveolar lavage (BAL), circulating tumor cells, hair follicles, and bone marrow. These specimens will be stored with unique identifiers and used to perform only those research studies that are outlined in this protocol. * For pediatric patients: tumor biopsy/resection tissue used for pediatric preclinical model development will only be from tissue already being obtained as part of a procedure necessary for the patient s clinical care or as part of a primary research protocol; blood specimens will be collected as part of a blood collection already scheduled for the patient s clinical care or as part of the planned pre-procedure bloodwork; volumes collected will not exceed institutional research limits. * Given the risks associated with any invasive procedure, such as tumor biopsy, the procedure will be discussed in detail with the patients and their parents/guardian (as indicated), including the side effects, prior to obtaining a separate consent for each procedure. A separate consent will not be signed prior to obtaining samples by minimally invasive measures, such as venipuncture. * This study has two separate consent forms at the NIH Clinical Center: one for adult patients to donate specimens for ongoing research on assay development and studies of molecular pathways, and one for adult and age-appropriate pediatric patients to donate samples for the generation of preclinical models. The study also has consent form templates for adult and pediatric patients at participating sites to donate specimens to create preclinical models. * Patients may remain on study for the duration of their consent or completion of the planned procedure, whichever comes first.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat i więcej
- •Diagnoza nowotworu złośliwego lub podejrzenie raka
- •Pacjent leczony w klinice NIH lub ośrodkach uczestniczących w badaniu
- •Możliwość podpisania świadomej zgody na uczestnictwo w badaniu
- •Potwierdzenie aktywnego nowotworu w badaniu patologicznym
- •Pacjent może być w trakcie leczenia lub przed jego rozpoczęciem
Simplified criteria — AI translation
Trial details
- Minimum age
- 2 Months
- Last updated (source)
- August 18, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (17)
UC Davis
Sacramento, United States
University of Colorado, Denver
Aurora, United States
Emory University
Atlanta, United States
Indiana University - Purdue
Indianapolis, United States
University of Iowa
Iowa City, United States
Johns Hopkins University
Baltimore, United States
National Institutes of Health Clinical Center
Bethesda, United States
University of Michigan Ann Arbor
Ann Arbor, United States
Washington University - St. Louis
St Louis, United States
Roswell Park Cancer Institute
Buffalo, United States
Ohio State University
Columbus, United States
University of Pittsburgh Medical Center
Pittsburgh, United States
Medical University of South Carolina
Charleston, United States
University of Utah
Salt Lake City, United States
University of Virginia, Charlottesville
Charlottesville, United States
Fred Hutchinson
Seattle, United States
Princess Margaret Hospital Cancer Centre
Toronto, Canada
Trial contact
Nancy A Moore, R.N.
James H Doroshow, M.D.
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/18/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.